Form 4: Third Rock Ventures IV, L.P. Sells 50,000 Shares of Tango Therapeutics

Third Rock Ventures IV, L.P., a significant shareholder of Tango Therapeutics, Inc. (TNGX), sold 50,000 shares of common stock at an average price of $9.839 per share on July 26, 2024.

Summary

• Third Rock Ventures IV, L.P. sold 50,000 shares of Tango Therapeutics, Inc. (TNGX) common stock on July 26, 2024.
• The shares were sold at a weighted average price of $9.839, with individual transactions ranging from $9.75 to $10.07.
• Following the transaction, Third Rock Ventures IV, L.P. directly holds 17,721,475 shares of Tango Therapeutics.
• The general partners of Third Rock Ventures IV, L.P. are Third Rock Ventures GP IV, L.P. and TRV GP IV, LLC, both of which disclaim beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative as a major shareholder is reducing their position, which could indicate a lack of confidence or a strategic portfolio adjustment. However, the remaining holdings are still substantial.

Negatives

• A major shareholder, Third Rock Ventures IV, L.P., has reduced its stake in Tango Therapeutics by selling 50,000 shares.

Risks

• Continued selling pressure from major shareholders could negatively impact the stock price.
• The weighted average sale price of $9.839 may indicate a perceived fair value by the seller, which could influence market sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or major shareholders of a publicly traded company buy or sell the company's stock. This filing indicates a change in ownership by a significant shareholder, which is closely watched by investors for insights into the company's prospects.

Comparison to Industry Standards

• Form 4 filings are a common occurrence for publicly traded companies, and the information provided is used by investors to assess the sentiment of insiders and major shareholders.
• The sale of shares by Third Rock Ventures IV, L.P. is similar to other instances where venture capital firms or large shareholders reduce their positions in portfolio companies after a certain period.

Stakeholder Impact

• Shareholders may react to the news of a major shareholder selling shares, potentially impacting the stock price.
• The sale could be perceived as a lack of confidence in the company's future prospects, although it could also be a routine portfolio adjustment.

Key Dates